305 related articles for article (PubMed ID: 9664200)
1. Management of travellers' diarrhoea.
Caeiro JP; DuPont HL
Drugs; 1998 Jul; 56(1):73-81. PubMed ID: 9664200
[TBL] [Abstract][Full Text] [Related]
2. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
DuPont HL
Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
[TBL] [Abstract][Full Text] [Related]
3. Travellers' diarrhoea. Which antimicrobial?
DuPont HL
Drugs; 1993 Jun; 45(6):910-917. PubMed ID: 7691498
[TBL] [Abstract][Full Text] [Related]
4. Travellers' diarrhoea.
Ericsson CD
Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: prevention of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2008 May; 27(9):741-51. PubMed ID: 18284650
[TBL] [Abstract][Full Text] [Related]
6. Review article: prevention and treatment of travellers' diarrhoea.
Farthing MJ
Aliment Pharmacol Ther; 1991 Feb; 5(1):15-30. PubMed ID: 1932478
[TBL] [Abstract][Full Text] [Related]
7. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503854
[TBL] [Abstract][Full Text] [Related]
8. Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2009 Aug; 30(3):187-96. PubMed ID: 19392866
[TBL] [Abstract][Full Text] [Related]
9. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2017 Apr; 24(suppl_1):S57-S62. PubMed ID: 28881862
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea.
Lääveri T; Sterne J; Rombo L; Kantele A
Travel Med Infect Dis; 2016; 14(4):299-312. PubMed ID: 27363327
[TBL] [Abstract][Full Text] [Related]
11. Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Layer P; Andresen V
Aliment Pharmacol Ther; 2010 Jun; 31(11):1155-64. PubMed ID: 20331580
[TBL] [Abstract][Full Text] [Related]
12. Travellers' diarrhoea: causes, prevention and treatment.
Lloyd R; Bennett C
Nurs Stand; 2012 Jun 6-12; 26(40):51-6; quiz 58. PubMed ID: 22848971
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.
Ng QX; Ho CYX; Shin D; Venkatanarayanan N; Chan HW
J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498921
[TBL] [Abstract][Full Text] [Related]
14. Medications for the prevention and treatment of travellers' diarrhea.
Taylor DN; Hamer DH; Shlim DR
J Travel Med; 2017 Apr; 24(suppl_1):S17-S22. PubMed ID: 28520998
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: a randomized prospective study.
Krokowicz L; Kaczmarek BF; Krokowicz P; Stojcev Z; Mackiewicz J; Walkowiak J; Drews M; Banasiewicz T
Travel Med Infect Dis; 2014; 12(2):183-8. PubMed ID: 24063909
[TBL] [Abstract][Full Text] [Related]
17. Symptoms of infectious diseases in HIV-positive travellers: A prospective study with exposure-matched controls.
Suryapranata F; Boyd A; Grobusch MP; Prins M; Sonder G
Travel Med Infect Dis; 2019; 29():28-33. PubMed ID: 30641130
[TBL] [Abstract][Full Text] [Related]
18. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
Frech SA; Dupont HL; Bourgeois AL; McKenzie R; Belkind-Gerson J; Figueroa JF; Okhuysen PC; Guerrero NH; Martinez-Sandoval FG; Meléndez-Romero JH; Jiang ZD; Asturias EJ; Halpern J; Torres OR; Hoffman AS; Villar CP; Kassem RN; Flyer DC; Andersen BH; Kazempour K; Breisch SA; Glenn GM
Lancet; 2008 Jun; 371(9629):2019-25. PubMed ID: 18554712
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
Ericsson CD
Drug Saf; 2006; 29(3):201-7. PubMed ID: 16524320
[TBL] [Abstract][Full Text] [Related]
20. Despite antibiotic treatment of travellers' diarrhoea, pathogens are found in stools from half of travellers at return.
Lääveri T; Vilkman K; Pakkanen S; Kirveskari J; Kantele A
Travel Med Infect Dis; 2018; 23():49-55. PubMed ID: 29702254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
